miR-149 controls non-alcoholic fatty liver by targeting FGF-21

Longitudinal study of circulating miR-122 in a rat model of non-alcoholic fatty liver disease

(2015) Hiroya Yamada et al.   CLINICA CHIMICA ACTA

Nonalcoholic fatty liver disease: Update on pathogenesis, diagnosis, treatment and the role of S-adenosylmethionine

(2015) Mazen Noureddin et al.   EXPERIMENTAL BIOLOGY AND MEDICINE

Downregulation of microRNA-451 in non-alcoholic steatohepatitis inhibits fatty acid-induced proinflammatory cytokine production through the AMPK/AKT pathway

(2015) Wonhee Hur et al.   INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY

miR-212 downregulation contributes to the protective effect of exercise against non-alcoholic fatty liver via targeting FGF-21

(2015) Junjie Xiao et al.   JOURNAL OF CELLULAR AND MOLECULAR MEDICINE

MicroRNA-149 Inhibits PARP-2 and Promotes Mitochondrial Biogenesis via SIRT-1/PGC-1α Network in Skeletal Muscle

(2014) Junaith S. Mohamed et al.   DIABETES

Autoregulation of glypican-1 by intronic microRNA-149 fine tunes the angiogenic response to FGF2 in human endothelial cells

(2014) A. Chamorro-Jorganes et al.   JOURNAL OF CELL SCIENCE

MicroRNAs as controlled systems and controllers in non-alcoholic fatty liver disease

(2014) Nadia Panera   WORLD JOURNAL OF GASTROENTEROLOGY

Nutrition, nonalcoholic fatty liver disease and the microbiome

(2013) Miriam B. Vos   CURRENT OPINION IN LIPIDOLOGY

Dual Role of MicroRNAs in NAFLD

(2013) Sara Ceccarelli et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

A Pre-microRNA-149 (miR-149) Genetic Variation Affects miR-149 Maturation and Its Ability to Regulate the Puma Protein in Apoptosis

(2013) Su-Ling Ding et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Association of the miR-146a , miR-149 , miR-196a2 , and miR-499 Polymorphisms With Ischemic Stroke and Silent Brain Infarction Risk

(2012) Young Joo Jeon et al.   ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY

Non-CpG island promoter hypomethylation and miR-149 regulate the expression ofSRPX2in colorectal cancer

(2012) Bodil Øster et al.   INTERNATIONAL JOURNAL OF CANCER

MicroRNA-204 is required for differentiation of human-derived cardiomyocyte progenitor cells

(2012) Junjie Xiao et al.   JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY

SP1 mediates the link between methylation of the tumour suppressor miR-149 and outcome in colorectal cancer

(2012) Feng Wang et al.   JOURNAL OF PATHOLOGY

MicroRNA-149 Inhibits Proliferation and Cell Cycle Progression through the Targeting of ZBTB2 in Human Gastric Cancer

(2012) Ying Wang et al.   PLoS One

Associations of lifestyle-related factors, hsa-miR-149 and hsa-miR-605 gene polymorphisms with gastrointestinal cancer risk

(2011) Zhang MW et al.   MOLECULAR CARCINOGENESIS

Nonalcoholic Fatty Liver Disease

(2011) Krzysztof Lukasz Kopec et al.   NUTRITION IN CLINICAL PRACTICE

MicroRNAs in Development and Disease

(2011) Danish Sayed et al.   PHYSIOLOGICAL REVIEWS

Nonalcoholic Fatty Liver Disease: A Review and Update

(2010) Jeffrey R. Lewis et al.   DIGESTIVE DISEASES AND SCIENCES

Nonalcoholic fatty liver disease and hepatocellular carcinoma: A weighty connection

(2010) Brad Q. Starley et al.   HEPATOLOGY

Origins and Mechanisms of miRNAs and siRNAs

(2009) Richard W. Carthew et al.   CELL

The FGF family: biology, pathophysiology and therapy

(2009) Andrew Beenken et al.   NATURE REVIEWS DRUG DISCOVERY

Biogenesis of small RNAs in animals

(2009) V. Narry Kim et al.   NATURE REVIEWS MOLECULAR CELL BIOLOGY